secwatch.observer — SEC 8-K summary
======================================

Issuer:     NovoCure Ltd (NVCR)
CIK:        0001645113
Form:       8-K
Filed at:   2026-09-09T11:02:29+00:00
Accession:  0001645113-26-000068
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NovoCure director Timothy Scannell retires from board effective Sept 2, 2026
----------------------------------------------------------------------------

- Timothy Scannell, a current director, retired from the Board effective September 2, 2026.
- His seat was formally vacated pursuant to the Company's Articles of Association.
- Retirement after five years of service; no disagreement with Company or management.
- No replacement director named in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645113/000164511326000068/0001645113-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645113/000164511326000068/nvcr-20260902.htm
  HTML page:      https://secwatch.observer/filing/0001645113-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer